Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Occupational Health & Safety (Waco, Tex.)
|
October 4, 2018
Real Threat or False Alarm: Aare You Prepared for the Next Time the Fire Alarm Sounds?
Dave Carter
Studies in Health Technology and Informatics
|
May 17, 2025
Automatic Annotation of Disposition Counts in News Articles
Simon Rodier, Dave Carter
Studies in Health Technology and Informatics
|
June 24, 2020
Global Public Health Surveillance Using Media Reports: Redesigning GPHIN
Dave Carter, Marta Stojanovic, Philip Hachey, et al.
Journal of Extracellular Vesicles
|
December 12, 2018
Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles
Rienk Nieuwland, Juan Manuel Falcon-Perez, Carolina Soekmadji, et al.
NDT Plus
|
May 8, 2015
A meta-analysis of the relative doses of erythropoiesis-stimulating agents in patients undergoing dialysis
Xavier Bonafont, Andreas Bock, Dave Carter, et al.
Cancer Chemotherapy and Pharmacology
|
November 6, 2013
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
Ana M Molina, Thomas E Hutson, James Larkin, et al.
Nephron. Clinical Practice
|
April 15, 2009
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet
Martin Wilkie, Giuseppe Pontoriero, Fernando Macário, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 8, 2008
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism
Piergiorgio Messa, Fernando Macário, Magdi Yaqoob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2024
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results
Giovanni Scambia, Ricardo Villalobos Valencia, Nicoletta Colombo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 20, 2026
Adverse event profile following maintenance olaparib in patients with BRCA-mutated platinum-sensitive relapsed serous ovarian cancer in the phase III SOLO2 trial
Jonathan A Ledermann, Alain Lortholary, Richard T Penson, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Occupational Health & Safety (Waco, Tex.)
|
October 4, 2018
Real Threat or False Alarm: Aare You Prepared for the Next Time the Fire Alarm Sounds?
Dave Carter
Studies in Health Technology and Informatics
|
May 17, 2025
Automatic Annotation of Disposition Counts in News Articles
Simon Rodier, Dave Carter
Studies in Health Technology and Informatics
|
June 24, 2020
Global Public Health Surveillance Using Media Reports: Redesigning GPHIN
Dave Carter, Marta Stojanovic, Philip Hachey, et al.
Journal of Extracellular Vesicles
|
December 12, 2018
Essentials of extracellular vesicles: posters on basic and clinical aspects of extracellular vesicles
Rienk Nieuwland, Juan Manuel Falcon-Perez, Carolina Soekmadji, et al.
NDT Plus
|
May 8, 2015
A meta-analysis of the relative doses of erythropoiesis-stimulating agents in patients undergoing dialysis
Xavier Bonafont, Andreas Bock, Dave Carter, et al.
Cancer Chemotherapy and Pharmacology
|
November 6, 2013
A phase 1b clinical trial of the multi-targeted tyrosine kinase inhibitor lenvatinib (E7080) in combination with everolimus for treatment of metastatic renal cell carcinoma (RCC)
Ana M Molina, Thomas E Hutson, James Larkin, et al.
Nephron. Clinical Practice
|
April 15, 2009
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet
Martin Wilkie, Giuseppe Pontoriero, Fernando Macário, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
January 8, 2008
The OPTIMA study: assessing a new cinacalcet (Sensipar/Mimpara) treatment algorithm for secondary hyperparathyroidism
Piergiorgio Messa, Fernando Macário, Magdi Yaqoob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 12, 2024
Olaparib as Treatment Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer: Phase III SOLO3 Study Final Overall Survival Results
Giovanni Scambia, Ricardo Villalobos Valencia, Nicoletta Colombo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
March 20, 2026
Adverse event profile following maintenance olaparib in patients with BRCA-mutated platinum-sensitive relapsed serous ovarian cancer in the phase III SOLO2 trial
Jonathan A Ledermann, Alain Lortholary, Richard T Penson, et al.
Page
of 2